Loading...
PolyNovo Limited
CALZF•PNK
Healthcare
Medical - Devices
$0.85
$-0.01(-1.08%)
PolyNovo Limited (CALZF) Financial Performance & Income Statement Overview
Review PolyNovo Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
58.17%
↑ 58.17%
Operating Income Growth
118.80%
↑ 118.80%
Net Income Growth
206.83%
↑ 206.83%
Operating Cash Flow Growth
162.08%
↑ 162.08%
Operating Margin
0.83%
↑ 0.83%
Gross Margin
34.97%
↑ 34.97%
Net Profit Margin
5.10%
↑ 5.10%
ROE
7.45%
↑ 7.45%
ROIC
1.007%
↑ 1.007%
PolyNovo Limited (CALZF) Income Statement & Financial Overview
Review PolyNovo Limited's (CALZF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $56.04M | $47.15M | $35.88M | $18.14M |
| Cost of Revenue | $36.56M | $30.55M | $25.64M | $3.61M |
| Gross Profit | $19.48M | $16.60M | $10.24M | $14.54M |
| Gross Profit Ratio | $0.35 | $0.35 | $0.29 | $0.80 |
| R&D Expenses | $6.06M | $4.87M | $4.39M | $2.20M |
| SG&A Expenses | $12.40M | $11.90M | $7.76M | $14.89M |
| Operating Expenses | $18.46M | $16.77M | $12.15M | $15.29M |
| Total Costs & Expenses | $55.02M | $47.31M | $37.79M | $18.90M |
| Interest Income | $677000.00 | $858000.00 | $797876.00 | $215329.00 |
| Interest Expense | $357000.00 | $364000.00 | $367219.00 | $0.00 |
| Depreciation & Amortization | $1.15M | $1.04M | $1.05M | $175672.00 |
| EBITDA | $2.13M | $2.49M | -$867260.00 | -$578531.00 |
| EBITDA Ratio | $0.04 | $0.02 | -$0.02 | -$0.03 |
| Operating Income | $1.03M | -$165000.00 | -$1.92M | -$754203.00 |
| Operating Income Ratio | $0.02 | -$0.003 | -$0.05 | -$0.04 |
| Other Income/Expenses (Net) | -$402000.00 | $1.25M | $1.38M | $1.26M |
| Income Before Tax | $624000.00 | $1.09M | -$1.08M | -$538874.00 |
| Income Before Tax Ratio | $0.01 | $0.02 | -$0.03 | -$0.03 |
| Income Tax Expense | -$1.94M | -$1.61M | $23004.00 | $11502.00 |
| Net Income | $2.57M | $2.69M | -$1.10M | -$550377.00 |
| Net Income Ratio | $0.05 | $0.06 | -$0.03 | -$0.03 |
| EPS | $0.004 | $0.004 | -$0.002 | -$0.001 |
| Diluted EPS | $0.004 | $0.004 | -$0.002 | -$0.001 |
| Weighted Avg Shares Outstanding | $690.23M | $690.23M | $690.23M | $704.71M |
| Weighted Avg Shares Outstanding (Diluted) | $702.18M | $698.68M | $690.23M | $704.64M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan